Drug Type Small molecule drug |
Synonyms Indisulam (USAN/INN) |
Target |
Mechanism DCAF15 inhibitors(DDB1 and CUL4 associated factor 15 inhibitors), RBM39 antagonists(RNA binding motif protein 39 antagonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H13ClN2O4S2 |
InChIKeyLZYRGBABRQXUHX-UHFFFAOYSA-N |
CAS Registry165668-45-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic breast cancer | Phase 2 | US | 01 Feb 2004 | |
Metastatic breast cancer | Phase 2 | US | 01 Feb 2004 | |
Metastatic breast cancer | Phase 2 | CA | 01 Feb 2004 | |
Metastatic breast cancer | Phase 2 | CA | 01 Feb 2004 | |
Neoplasm Metastasis | Phase 2 | US | 01 Feb 2004 | |
Metastatic Colorectal Carcinoma | Phase 2 | FR | 01 Mar 2003 | |
Metastatic Colorectal Carcinoma | Phase 2 | DE | 01 Mar 2003 | |
Metastatic Colorectal Carcinoma | Phase 2 | NL | 01 Mar 2003 | |
Metastatic Clear Cell Renal Cell Carcinoma | Phase 2 | FR | 01 May 2002 | |
Metastatic Clear Cell Renal Cell Carcinoma | Phase 2 | US | 01 May 2002 |
Phase 2 | 43 | wggofioeaa(zsujphcpsr) = ffugghjnrv oxleihbokz (nrrhmogtue, clisiufjvf - gvmdffugqc) | - | 03 Jul 2018 | |||
Phase 1 | - | (avbycphtcr) = wpkxbobaex lcphabvbtk (uokmhgqupq ) View more | - | 01 Jun 2005 | |||
(avbycphtcr) = ulqudpndwz lcphabvbtk (uokmhgqupq ) | |||||||
Phase 2 | 49 | (fzeltcxuji) = ofmuyvcyez wcgafspnmw (vzteqeifgq ) | - | 01 Jun 2005 |